226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-56.86%
Negative net income growth while JD stands at 10.51%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.50%
D&A growth of 7.50% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-120.00%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
172.73%
SBC growth of 172.73% while JD is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
123.67%
Working capital change of 123.67% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-68.00%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-9.09%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
100.90%
AP growth of 100.90% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
329.41%
Growth of 329.41% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-33.33%
Both negative yoy, with JD at -301.39%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
142.90%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-26.09%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
96.43%
Acquisition growth of 96.43% while JD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-78.46%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-13.54%
We reduce yoy sales while JD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
150.00%
Growth well above JD's 248.67%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-148.81%
We reduce yoy invests while JD stands at 230.06%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
93.29%
Debt repayment growth of 93.29% while JD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-107.14%
Negative yoy issuance while JD is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.